These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25642266)

  • 1. Triclabendazole Effect on Protease Enzyme Activity in the Excretory- Secretory Products of Fasciola hepatica in Vitro.
    Shrifi Y; Farahnak A; Golestani A; Eshraghian MR; Faridi A; Molaei Rad MB
    Iran J Parasitol; 2014 Mar; 9(1):107-13. PubMed ID: 25642266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro effects of triclabendazole (TCBZ) on the excretory-secretory products (ESP) of Fasciola spp parasites.
    Farahnak A; Golmohamdi T; Eshraghian M
    Acta Med Iran; 2012; 50(3):164-8. PubMed ID: 22418984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triclabendazole (Anthelmintic Drug) Effects on the Excretory- Secretory Proteome of Fasciola hepatica in Two Dimension Electrophoresis Gel.
    Faridi A; Farahnak A; Golmohammadi T; Eshraghian M; Sharifi Y; Molaei Rad M
    Iran J Parasitol; 2014; 9(2):202-8. PubMed ID: 25848386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme-linked immunoelectrotransfer blot analysis of excretory-secretory proteins of Fascioloides magna and Fasciola hepatica.
    Qureshi T; Wagner GG; Drawe DL; Davis DS; Craig TM
    Vet Parasitol; 1995 Jul; 58(4):357-63. PubMed ID: 8533275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal amplification of Fasciola hepatica in Galba truncatula: within and between isolate variation of triclabendazole-susceptible and -resistant clones.
    Hodgkinson JE; Cwiklinski K; Beesley N; Hartley C; Allen K; Williams DJL
    Parasit Vectors; 2018 Jun; 11(1):363. PubMed ID: 29941045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triclabendazole biotransformation and comparative diffusion of the parent drug and its oxidized metabolites into Fasciola hepatica.
    Mottier L; Virkel G; Solana H; Alvarez L; Salles J; Lanusse C
    Xenobiotica; 2004; 34(11-12):1043-57. PubMed ID: 15801547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of Superoxide Dismutase (SOD) Enzyme in the Excretory-Secretory Products of Fasciola hepatica and F. gigantica Parasites.
    Farahnak A; Golestani A; Eshraghian M
    Iran J Parasitol; 2013 Jan; 8(1):167-70. PubMed ID: 23682275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasciola hepatica: Histology of the Reproductive Organs and Differential Effects of Triclabendazole on Drug-Sensitive and Drug-Resistant Fluke Isolates and on Flukes from Selected Field Cases.
    Hanna R
    Pathogens; 2015 Jun; 4(3):431-56. PubMed ID: 26131614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardisation of a coproantigen reduction test (CRT) protocol for the diagnosis of resistance to triclabendazole in Fasciola hepatica.
    Flanagan AM; Edgar HW; Forster F; Gordon A; Hanna RE; McCoy M; Brennan GP; Fairweather I
    Vet Parasitol; 2011 Feb; 176(1):34-42. PubMed ID: 21093156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasciola hepatica: a comparative survey of adult fluke resistance to triclabendazole, nitroxynil and closantel on selected upland and lowland sheep farms in Northern Ireland using faecal egg counting, coproantigen ELISA testing and fluke histology.
    Hanna RE; McMahon C; Ellison S; Edgar HW; Kajugu PE; Gordon A; Irwin D; Barley JP; Malone FE; Brennan GP; Fairweather I
    Vet Parasitol; 2015 Jan; 207(1-2):34-43. PubMed ID: 25529143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative assessment of albendazole and triclabendazole ovicidal activity on Fasciola hepatica eggs.
    Alvarez L; Moreno G; Moreno L; Ceballos L; Shaw L; Fairweather I; Lanusse C
    Vet Parasitol; 2009 Oct; 164(2-4):211-6. PubMed ID: 19560276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confirmation of Fasciola hepatica resistant to triclabendazole in naturally infected Australian beef and dairy cattle.
    Brockwell YM; Elliott TP; Anderson GR; Stanton R; Spithill TW; Sangster NC
    Int J Parasitol Drugs Drug Resist; 2014 Apr; 4(1):48-54. PubMed ID: 24596668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single amino acid substitution in isozyme GST mu in Triclabendazole resistant Fasciola hepatica (Sligo strain) can substantially influence the manifestation of anthelmintic resistance.
    Fernández V; Estein S; Ortiz P; Luchessi P; Solana V; Solana H
    Exp Parasitol; 2015 Dec; 159():274-9. PubMed ID: 26542261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein Detection of Excretory-Secretory Products and Somatic Extracts from
    Rasouli A; Farahnak A; Zali H; Rezaeian M; Golestani A; Molaei Rad MB
    Iran J Parasitol; 2019; 14(3):379-386. PubMed ID: 31673255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and biochemical characterization of a 22-kDa stable cysteine- like protease from the excretory-secretory product of the liver fluke Fasciola hepatica by using conventional techniques.
    Hemici A; Benerbaiha RS; Bendjeddou D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():268-276. PubMed ID: 29132905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two assays, a faecal egg count reduction test (FECRT) and a coproantigen reduction test (CRT), for the diagnosis of resistance to triclabendazole in Fasciola hepatica in sheep.
    Flanagan A; Edgar HW; Gordon A; Hanna RE; Brennan GP; Fairweather I
    Vet Parasitol; 2011 Mar; 176(2-3):170-6. PubMed ID: 21112153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase of gluthatione S-transferase, carboxyl esterase and carbonyl reductase in Fasciola hepatica recovered from triclabendazole treated sheep.
    Scarcella S; Solana MV; Fernandez V; Lamenza P; Ceballos L; Solana H
    Mol Biochem Parasitol; 2013 Oct; 191(2):63-5. PubMed ID: 24041589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of Fasciola hepatica against Triclabendazole in cattle in Cajamarca (Peru): a clinical trial and an in vivo efficacy test in sheep.
    Ortiz P; Scarcella S; Cerna C; Rosales C; Cabrera M; Guzmán M; Lamenza P; Solana H
    Vet Parasitol; 2013 Jul; 195(1-2):118-21. PubMed ID: 23352107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasciola hepatica: histological demonstration of apoptosis in the reproductive organs of flukes of triclabendazole-sensitive and triclabendazole-resistant isolates, and in field-derived flukes from triclabendazole-treated hosts, using in situ hybridisation to visualise endonuclease-generated DNA strand breaks.
    Hanna RE; Forster FI; Brennan GP; Fairweather I
    Vet Parasitol; 2013 Jan; 191(3-4):240-51. PubMed ID: 23062689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experiments on anthelmintic control of Fasciola hepatica in Brazil.
    Echevarria FA; Correa MB; Wehrle RD; Correa IF
    Vet Parasitol; 1992 Jul; 43(3-4):211-22. PubMed ID: 1413453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.